Computational Biology Market Size & Share, by Application (Cellular & Biological Simulation, Drug Discovery, Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation); Component (Databases, Infrastructure Hardware, Analysis Services); End-user (Academics, Industrial, Commercials) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3921
  • Published Date: May 30, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Computational Biology Market size is projected to surpass USD 59 Billion by the end of 2035, growing at a CAGR of 20% during the forecast period i.e., 2023-2035. In the year 2022, the industry size of computational biology was USD 6.6 Billion. The growth of the market can be attributed to the increasing use of computational approaches in the biological sciences to determine experimental data including genetic sequences, cell count, and protein sample detection for the discovery of new solutions in biology. The growing application of analytical methods, simulation technology, and mathematical modeling with computational models helps to discover new genomics and protein structures, propelling the market growth.

In addition to these, the rising need to prove many theoretical explanations in real-time applications is expected to drive the computational biology market growth. Increasing demand for bioinformatics, and growing clinical studies in the field of pharmacokinetics and pharmacogenomics with growing disease modeling. Further, escalating experiments to find the origin of the virus, host, and the virus evolution is driving the market demand. 

Computational Biology Market
Get more information on this report: Request Free Sample PDF

Computational Biology Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Research and Development in the Field of Technology – The increasing implementation of artificial intelligence and other network models to develop human brains, and study various organ anatomy is fueling the market growth. For instance, Human Genome Project is one such use of artificial technology in biology.
  • Increasing Demand for Personalized Medicines – The applications for personalized medicine in targeted therapies for the treatment of cancer tumors and to treat patients with allergies, organ dysfunction, and vulnerable disease states will boost the computational biology market expansion.
  • Growing Drug Discovery Owing to the Incidence of Diseases such as COVID-19 – The rising requirement to treat untreatable diseases and the occurrence of new diseases, to reduce the cost of medicines, and prevent drug resistance is propelling the growth of drug discovery and thereby the use of computational biology.


  • Dearth of Skilled Personnel – The dearth of experienced and skilled professionals is estimated to hamper the computational biology market growth. The discovery of drugs in computational biology needs the knowledge of pharmaceuticals, pharmacology, and technological advancements. Specialized doctors and clinical research personnel as required to perform computational analytics.
  • Presence of Complications
  • High Investment Cost and Maintenance Price

Computational Biology Market: Key Insights

Base Year


Forecast Year



~ 20%

Base Year Market Size (2022)

~ USD 6.6 Billion

Forecast Year Market Size (2035)

~ USD 59 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Computational Biology Segmentation

Application (Cellular & Biological Simulation, Drug Discovery, Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation)

The drug discovery segment is projected to garner a significant share of the computational biology market in the coming years, owing to the potential need for new medicines across the world. Drug discovery in general includes the involvement of complex processes such as pharmacological studies for the determination of drug efficacy, metabolic stability, bioavailability, and side effects in humans. These processes need permissions and funds from the government to perform which on the other hand drug discovery is done through computational technology on less budget.

The use of computational pharmacology helps to study the relation between genomic effects and diseases and the effects of drugs with the use of Microsoft Excel which propels the growth of the segment.

End-User (Academics, Industry, Commercials, Others)

The commercial segment is estimated to register a noteworthy computational biology market share during the forecast period with the increasing commercial investments by organizations in the research and development activities of the healthcare sector. Also, the growing privatization of the healthcare industry is estimated to boost the segment growth.

The increasing investment in genetic technology such as genetic engineering, genomics, automated cell culture, DNA sequencing, and cell biology is anticipated to hike the market demand. The net private equity and venture capital investment in the year 2021 increased at a rate of over 15% from 2010 for the life science category as per the estimations.

Our in-depth analysis of the global market includes the following segments:


  • Cellular and Biological Simulation
  • Drug Discovery
  • Disease Modelling
  • Preclinical Drug Development
  • Clinical Trials
  • Human Body Simulation
  • Others


  • Databases
  • Infrastructure Hardware
  • Analysis Services
  • Others

   End User

  • Academics
  • Industry
  • Commercials
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Computational Biology Industry - Regional Synopsis

North American Market Forecast

North America region is anticipated to gain the largest computational biology market share till 2035, due to the growing R&D activities, coupled with the high investment in research activities.

The growing foothold of the United States in synthetic biology is predicted to promote lucrative opportunities for the market expansion. The advancement of the region in the application of machine learning tools and analytical tools will further influence the market growth.

APAC Market Statistics

Asia Pacific computational biology market is expected to witness substantial demand through 2035. The increasing presence of contract research organizations in the region that reduce the cost of drug development for many pharmaceutical industries will propel the market revenue.

The Asian market is popular for the manufacturing of generic drugs and biosimilars which is much essential to decrease healthcare expenditure and is set to drive the use of computational biology in the region.

Research Nester
Computational Biology Market Share
Get more information on this report: Request Free Sample PDF

Companies dominating the Global Computational Biology Landscape

    • Dassault Systèmes SE
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Certara Inc.
    • Instem Group
    • Compugen
    • Chemical Computing Group ULC
    • Rhenovia Pharma SAS
    • Nimbus Discovery LLC
    • Rhenovia Pharma SAS
    • Insilico Biotechnology AG
    • Genedata AG

In the News

Certara Inc. announced that the U.S. Food and Drug Administration (FDA) has renewed and expanded the company’s licenses of Certra’s proprietarybiosimulation software along with other 400 user licenses of Phoenix software and Simcyp.

Instem Group declared the acquisition of Edge Software Consultancy Ltd to expand its portfolio to discover R&D activities thereby bringing the client products into the market at a faster rate. The technology and services of the Edge helped to enhance the research and development activities of drug discovery and increased client productivity.


Author Credits:  Radhika Pawar

  • Report ID: 3921
  • Published Date: May 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing investment in research and development activities and growing demand for bioinformatics are the major factors driving the market growth.

The market size of computational biology is anticipated to attain a CAGR of ~20% over the forecast period, i.e., 2023-2035.

Lack of enough researchers and dearth of trained professionals are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Certara Inc., Instem Group, Compugen, Chemical Computing Group ULC, Rhenovia Pharma SAS, Nimbus Discovery LLC, Rhenovia Pharma SAS, Insilico Biotechnology AG, Genedata AG, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, component, end-user, and by region.

The commercial segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Computational Biology Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying